JP2023511441A5 - - Google Patents
Info
- Publication number
- JP2023511441A5 JP2023511441A5 JP2022544753A JP2022544753A JP2023511441A5 JP 2023511441 A5 JP2023511441 A5 JP 2023511441A5 JP 2022544753 A JP2022544753 A JP 2022544753A JP 2022544753 A JP2022544753 A JP 2022544753A JP 2023511441 A5 JP2023511441 A5 JP 2023511441A5
- Authority
- JP
- Japan
- Prior art keywords
- glu
- ethoxy
- acetyl
- aminoethoxy
- co2h
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025195273A JP2026069790A (ja) | 2020-01-23 | 2025-11-14 | Ｇｉｐ／ｇｌｐ１共アゴニスト化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062964932P | 2020-01-23 | 2020-01-23 | |
| US62/964,932 | 2020-01-23 | ||
| PCT/US2021/014302 WO2021150673A1 (en) | 2020-01-23 | 2021-01-21 | Gip/glp1 co-agonist compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025195273A Division JP2026069790A (ja) | 2020-01-23 | 2025-11-14 | Ｇｉｐ／ｇｌｐ１共アゴニスト化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023511441A JP2023511441A (ja) | 2023-03-17 |
| JP2023511441A5 true JP2023511441A5 (https=) | 2024-01-25 |
Family
ID=74592824
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022544753A Pending JP2023511441A (ja) | 2020-01-23 | 2021-01-21 | Ｇｉｐ／ｇｌｐ１共アゴニスト化合物 |
| JP2025195273A Pending JP2026069790A (ja) | 2020-01-23 | 2025-11-14 | Ｇｉｐ／ｇｌｐ１共アゴニスト化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025195273A Pending JP2026069790A (ja) | 2020-01-23 | 2025-11-14 | Ｇｉｐ／ｇｌｐ１共アゴニスト化合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230265151A1 (https=) |
| EP (1) | EP4093757A1 (https=) |
| JP (2) | JP2023511441A (https=) |
| KR (1) | KR20220131292A (https=) |
| CN (1) | CN115298207A (https=) |
| AR (1) | AR121093A1 (https=) |
| AU (1) | AU2021211451B2 (https=) |
| BR (1) | BR112022014397A2 (https=) |
| CA (1) | CA3165430A1 (https=) |
| IL (1) | IL294955A (https=) |
| MX (1) | MX2022009149A (https=) |
| TW (1) | TWI770781B (https=) |
| WO (1) | WO2021150673A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR113486A1 (es) * | 2017-12-21 | 2020-05-06 | Lilly Co Eli | Análogos de incretina y sus usos |
| CA3204051A1 (en) | 2021-01-20 | 2022-07-28 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| CN117320740A (zh) * | 2021-02-17 | 2023-12-29 | 伊莱利利公司 | Gip/glp1双重激动剂治疗方法 |
| WO2023029380A1 (zh) | 2021-08-30 | 2023-03-09 | 杭州德睿智药科技有限公司 | 作为glp1r激动剂的新型芳醚取代杂环类化合物 |
| JP7642830B2 (ja) | 2021-09-15 | 2025-03-10 | バイキング・セラピューティクス・インコーポレイテッド | 代謝及び肝臓障害の処置のための組成物及び方法 |
| CN117586373A (zh) * | 2022-08-10 | 2024-02-23 | 成都奥达生物科技有限公司 | 一种长效双激动剂化合物 |
| CN116023444B (zh) * | 2022-08-12 | 2023-08-01 | 重庆宸安生物制药有限公司 | 一种gip和glp-1双受体激动剂多肽化合物及其应用 |
| WO2024165571A2 (en) | 2023-02-06 | 2024-08-15 | E-Therapeutics Plc | Inhibitors of expression and/or function |
| WO2025125576A2 (en) | 2023-12-15 | 2025-06-19 | E-Therapeutics Plc | Inhibitors of expression and/or function |
| WO2025133348A1 (en) | 2023-12-22 | 2025-06-26 | E-Therapeutics Plc | Inhibitors of expression and/or function |
| EP4686757A1 (en) | 2024-07-31 | 2026-02-04 | e-therapeutics PLC | Inhibitors of expression and/or function |
| WO2025196502A1 (en) | 2024-03-20 | 2025-09-25 | North Carolina Agricultural & Technical State University | Choline kinase inhibitors as a therapeutic treatment for obesity |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR080592A1 (es) * | 2010-03-26 | 2012-04-18 | Lilly Co Eli | Peptido con actividad para el gip-r y glp-1-r, formulacion famaceutica que lo comprende, su uso para preparar un medicamento util para el tratamiento de diabetes mellitus y para inducir la perdida de peso |
| US9453062B2 (en) * | 2011-06-10 | 2016-09-27 | Beijing Hanmi Pharmaceutical Co., Ltd. | Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof |
| IN2014MN02304A (https=) * | 2012-05-03 | 2015-08-07 | Zealand Pharma As | |
| AU2013366692B2 (en) * | 2012-12-21 | 2017-11-23 | Sanofi | Dual GLP1/GIP or trigonal GLP1/GIP/Glucagon agonists |
| WO2015067715A2 (en) * | 2013-11-06 | 2015-05-14 | Zealand Pharma A/S | Gip-glp-1 dual agonist compounds and methods |
| TWI582109B (zh) * | 2015-01-09 | 2017-05-11 | 美國禮來大藥廠 | Ｇｉｐ及ｇｌｐ－１共促效劑化合物 |
| TWI700291B (zh) * | 2015-06-22 | 2020-08-01 | 美國禮來大藥廠 | 升糖素及glp-1共激動劑化合物 |
| TWI767095B (zh) * | 2017-12-21 | 2022-06-11 | 美商美國禮來大藥廠 | 腸促胰島素(incretin)類似物及其用途 |
| KR20240051304A (ko) * | 2018-07-23 | 2024-04-19 | 일라이 릴리 앤드 캄파니 | Gip/glp1 공효능제 화합물 |
-
2021
- 2021-01-21 IL IL294955A patent/IL294955A/en unknown
- 2021-01-21 BR BR112022014397A patent/BR112022014397A2/pt unknown
- 2021-01-21 MX MX2022009149A patent/MX2022009149A/es unknown
- 2021-01-21 JP JP2022544753A patent/JP2023511441A/ja active Pending
- 2021-01-21 TW TW110102332A patent/TWI770781B/zh active
- 2021-01-21 KR KR1020227028667A patent/KR20220131292A/ko not_active Withdrawn
- 2021-01-21 CA CA3165430A patent/CA3165430A1/en active Pending
- 2021-01-21 CN CN202180023819.8A patent/CN115298207A/zh active Pending
- 2021-01-21 EP EP21705072.3A patent/EP4093757A1/en active Pending
- 2021-01-21 AR ARP210100135A patent/AR121093A1/es unknown
- 2021-01-21 AU AU2021211451A patent/AU2021211451B2/en active Active
- 2021-01-21 US US17/794,128 patent/US20230265151A1/en active Pending
- 2021-01-21 WO PCT/US2021/014302 patent/WO2021150673A1/en not_active Ceased
-
2025
- 2025-11-14 JP JP2025195273A patent/JP2026069790A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023511441A5 (https=) | ||
| CN103998063B (zh) | 聚乙二醇基肾上腺髓质素前药及其用途 | |
| AU2022311814A1 (en) | Lipidated peptide inhibitors of interleukin-23 receptor | |
| CN105849100B (zh) | 流感病毒复制抑制剂 | |
| EP2427475B1 (en) | High penetration prodrug compositions of peptides and peptide-related compounds | |
| IL325353A (en) | Incretin analogs and their use | |
| JP2022095872A5 (https=) | ||
| JP2021191796A (ja) | アザインドール化合物の製剤 | |
| CN116710462A (zh) | 用于治疗代谢病症和肝病的组合物和方法 | |
| JP2009503020A5 (https=) | ||
| RU2012128547A (ru) | Дважды ацилированные производные glp-1 | |
| JP2013501802A5 (https=) | ||
| JP2025134881A (ja) | Ｓａｒｓの治療のための化合物 | |
| JP2007529528A5 (https=) | ||
| JP2011505356A5 (https=) | ||
| WO2012067138A1 (ja) | 新規なシチジン系代謝拮抗剤の高分子誘導体 | |
| JP2019530674A5 (https=) | ||
| JP2023017793A (ja) | エラスターゼ阻害活性を有するベータヘアピンペプチド模倣体及びそのエアロゾル剤形 | |
| JP2022543826A5 (https=) | ||
| JP2025118775A5 (https=) | ||
| JP2026067913A (ja) | 新規なペプチドと多糖類とのコンジュゲート | |
| CN101631558A (zh) | 基于艾塞那肽和达拉根的用于治疗糖尿病的药物、其用途和治疗模式 | |
| CN118108832A (zh) | 一种长效的类似胰淀素的多肽衍生物及其制备方法和用途 | |
| TW201127387A (en) | Therapeutic or preventive agents for diabetes | |
| TW533074B (en) | Preventives/remedies for multiple organ failure |